Zhang Yanchao, Fang Qing, Peng Yue, Liu Honglin, Tang Jiancheng, Ma Ruichen, Wang Weiguo
Department of Orthopedics, China-Japan Friendship Hospital, Beijing, 100029, China.
Peking Union Medical College, Beijing, China.
J Orthop Translat. 2025 May 10;52:376-386. doi: 10.1016/j.jot.2025.05.002. eCollection 2025 May.
BACKGROUND: Transplantation of cartilaginous organoids for repairing cartilage defects in osteoarthritis represents a novel treatment approach. However, A controversial argument remains about whether cartilaginous organoids derived from the differentiation of bone marrow mesenchymal stem cells (BMSCs) in the three-dimensional (3D) environment are strictly organoids and whether the inflammatory microenvironment would affect the success rate of organoid transplantation. This study characterized 3D BMSC-derived cartilaginous organoids and developed an inflammatory organoid model to better understand the transcriptomic changes in the organoids induced by the microenvironment when transplanted into the knee with osteoarthritis. METHODS: Spatial growth BMSCs were generated and cultured in the cartilage differentiation medium to establish cartilaginous organoids. The model was characterized in both morphology and biology aspects. Subsequently, IL-1β induced inflammatory cartilaginous organoids were established and the transcriptomic sequencing was performed to investigate gene expression changes. RESULTS: BMSC-derived cartilaginous organoids were characterized by histology and immunofluorescence. Both Alcian blue and Safranin O staining revealed abundant articular cartilage extracellular matrix (ECM) in the organoids. The expression of cartilage specific ACAN and Col2A1 was confirmed by immunofluorescence. The organoids had the biological ability to repair cartilage defects. IL-1β induced inflammatory cartilaginous organoids were established and mRNA sequencing revealed downregulation of pathways related to cell adhesion and extracellular matrix organization. Upregulation of IL-6, TNF-α, CCL2 and CXCL1 was confirmed. CONCLUSION: We thoroughly validated and characterized BMSC-derived cartilaginous organoids and established the inflammatory cartilaginous organoid models. This study revealed that the attenuation in cell adhesion and ECM formation of organoids induced by inflammatory chemokines may decrease the success rate and effectiveness of organoids auto-transplantation for fixing cartilage defects in the inflammatory microenvironment of the OA joint. THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE: By establishing and validating an in vitro inflammatory cartilaginous organoid model, this study provides a robust platform to examine how inflammatory mediators influence cartilage-like constructs. These findings enable the identification of targeted interventions to enhance the organoids' resilience against the inflammatory environment commonly found in osteoarthritic joints. Ultimately, this strategy offers a novel avenue for improving transplant success and promoting cartilage defect repair in patients with OA, thereby contributing valuable insights and potential clinical applications in regenerative medicine.
背景:移植软骨类器官用于修复骨关节炎中的软骨缺损是一种新型治疗方法。然而,关于在三维(3D)环境中由骨髓间充质干细胞(BMSC)分化而来的软骨类器官是否严格意义上属于类器官,以及炎症微环境是否会影响类器官移植成功率,仍存在争议。本研究对3D BMSC来源的软骨类器官进行了表征,并建立了炎症类器官模型,以更好地了解移植到骨关节炎膝关节后,微环境诱导的类器官转录组变化。 方法:生成空间生长的BMSC并在软骨分化培养基中培养以建立软骨类器官。从形态学和生物学方面对该模型进行表征。随后,建立IL-1β诱导的炎症软骨类器官并进行转录组测序以研究基因表达变化。 结果:通过组织学和免疫荧光对BMSC来源的软骨类器官进行表征。阿尔新蓝和番红O染色均显示类器官中存在丰富的关节软骨细胞外基质(ECM)。通过免疫荧光证实了软骨特异性ACAN和Col2A1的表达。类器官具有修复软骨缺损的生物学能力。建立了IL-1β诱导的炎症软骨类器官,mRNA测序显示与细胞粘附和细胞外基质组织相关的通路下调。证实了IL-6、TNF-α、CCL2和CXCL1的上调。 结论:我们全面验证并表征了BMSC来源的软骨类器官,并建立了炎症软骨类器官模型。本研究表明,炎症趋化因子诱导的类器官细胞粘附和ECM形成减弱可能会降低类器官自体移植修复OA关节炎症微环境中软骨缺损的成功率和有效性。 本文的转化潜力:通过建立和验证体外炎症软骨类器官模型,本研究提供了一个强大的平台来研究炎症介质如何影响软骨样构建体。这些发现有助于确定靶向干预措施,以增强类器官对骨关节炎关节中常见炎症环境的抵抗力。最终,该策略为提高OA患者的移植成功率和促进软骨缺损修复提供了一条新途径,从而为再生医学提供了有价值的见解和潜在的临床应用。
Tissue Eng Part A. 2017-11-30
Front Bioeng Biotechnol. 2025-7-23
J Orthop Translat. 2025-7-16
J Orthop Translat. 2025-6-4
Theranostics. 2025-1-1
Bone Res. 2024-11-20
Smart Med. 2022-12-27
Smart Med. 2024-2-24
Adv Healthc Mater. 2024-9
J Transl Med. 2023-12-21
Front Bioeng Biotechnol. 2023-11-9